Anti-CD7 CAR-T Cells in Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia or Lymphoma
Conditions
- T-Cell Acute Lymphoblastic Leukemia/Lymphoma
Interventions
- BIOLOGICAL: Allogeneic anti-CD7 CAR-T cells (BEAM-201)
Sponsor
Stephan Grupp MD PhD
Collaborators